Uniphos Enterprises growth over the years

Compounded a year1 yr3 yr
Revenue−71.3%+179.0%
Net Income+7,363.9%−19.2%
EPS (adj.)+7,363.9%−19.2%
Total Assets−7.8%−5.4%
Total Equity−10.8%−6.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

UNIENTER₹85.24

Uniphos Enterprises Limited

· Chemicals
₹ CrorePeersVINYLINDIASRDMcap ₹593 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue-71.3+179.0
Net Income+7363.9-19.2
EPS (adj.)+7363.9-19.2
Total Assets-7.8-5.4
Total Equity-10.8-6.5
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.